Your browser doesn't support javascript.
loading
Smart conjugated polymer nanocarrier for healthy weight loss by negative feedback regulation of lipase activity.
Chen, Yu-Lei; Zhu, Sha; Zhang, Lei; Feng, Pei-Jian; Yao, Xi-Kuang; Qian, Cheng-Gen; Zhang, Can; Jiang, Xi-Qun; Shen, Qun-Dong.
Afiliación
  • Chen YL; Department of Polymer Science & Engineering and Key Laboratory of High Performance Polymer Materials & Technology of MOE, School of Chemistry & Chemical Engineering, Nanjing University, Nanjing 210093, P. R. China. qdshen@nju.edu.cn.
Nanoscale ; 8(6): 3368-75, 2016 Feb 14.
Article en En | MEDLINE | ID: mdl-26790821
Healthy weight loss represents a real challenge when obesity is increasing in prevalence. Herein, we report a conjugated polymer nanocarrier for smart deactivation of lipase and thus balancing calorie intake. After oral administration, the nanocarrier is sensitive to lipase in the digestive tract and releases orlistat, which deactivates the enzyme and inhibits fat digestion. It also creates negative feedback to control the release of itself. The nanocarrier smartly regulates activity of the lipase cyclically varied between high and low levels. In spite of high fat diet intervention, obese mice receiving a single dose of the nanocarrier lose weight over eight days, whereas a control group continues the tendency to gain weight. Daily intragastric administration of the nanocarrier leads to lower weight of livers or fat pads, smaller adipocyte size, and lower total cholesterol level than that of the control group. Near-infrared fluorescence of the nanocarrier reveals its biodistribution.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Pérdida de Peso / Fármacos Antiobesidad / Nanopartículas / Lactonas / Lipasa Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Nanoscale Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Pérdida de Peso / Fármacos Antiobesidad / Nanopartículas / Lactonas / Lipasa Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Nanoscale Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido